遗传性出血性疾病患者的结直肠癌筛查:血友病患者中癌症检出率高
本研究为荷兰全国性多中心横断面研究,纳入493例血友病或血管性血友病患者,评估粪便免疫化学检测(FIT)筛查结直肠癌的性能。血友病和血管性血友病患者FIT阳性率和假阳性率均显著高于一般人群,血友病患者结直肠癌/进展期腺瘤检出率显著高于一般男性人群,而血管性血友病患者检出率与一般人群相似但阳性预测值显著较低。
要点
- 血友病患者FIT阳性率14.8%、假阳性率10.3%,均显著高于一般人群。
- 血友病患者结直肠癌/进展期腺瘤检出率4.5%,显著高于一般男性人群的1.8%。
- 血管性血友病患者FIT阳性预测值6.3%,显著低于一般人群的36.8%。
核心结论
- 尽管遗传性出血性疾病患者FIT假阳性率高,但血友病患者结直肠癌和/或进展期腺瘤检出率高。
- FIT在血友病或血管性血友病患者中的表现与一般人群不同。
研究设计与样本
- 多中心、全国性横断面研究,嵌入2项荷兰全国性血友病和血管性血友病研究。
- 共纳入493例血友病(n=329)或血管性血友病(n=164)患者,其中351例参与了结直肠癌筛查项目(71.2%)。
主要发现
- 血友病患者FIT阳性率14.8% vs 一般人群4.3%(p<.001),假阳性率10.3% vs 2.3%(p<.001)。
- 血友病患者结直肠癌/进展期腺瘤检出率4.5% vs 一般男性人群1.8%(p=.02),FIT阳性预测值32.3% vs 39.7%(n.s.)。
- 血管性血友病患者结直肠癌/进展期腺瘤检出率0.8% vs 一般人群1.4%(n.s.),FIT阳性预测值6.3% vs 36.8%(p=.02)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The population-based colorectal cancer (CRC) screening program in individuals aged 55 to 75 years in the Netherlands uses fecal immunochemical testing (FIT), to detect hemoglobin in feces, followed by colonoscopy in individuals with a positive FIT. OBJECTIVES: The objectives of this study are to assess the false-positive rate, detection rate, and positive predictive value of FIT for CRC and advanced adenoma (AA) in patients with Von Willebrand disease (VWD) or hemophilia. METHODS: We performed a multicenter, nationwide cross-sectional study embedded in 2 nationwide studies on VWD and hemophilia in the Netherlands. RESULTS: In total, 493 patients with hemophilia (n = 329) or VWD (n = 164) were included, of whom 351 patients participated in the CRC screening program (71.2%). FIT positivity and false-positive rate in patients with hemophilia and VWD were significantly higher than those in the general population (14.8% vs. 4.3%, p < .001 and 10.3% vs. 2.3%, p <.001, respectively). In patients with hemophilia, the detection rate of CRC/AA was significantly higher than that in the general male population (4.5% vs. 1.8%, p = .02), and the positive predictive value of FIT for CRC/AA was comparable (32.3% vs. 39.7%, n.s.). In patients with VWD, the detection rate was similar to that of the general population (0.8% vs. 1.4%, n.s.), whereas the positive predictive value was significantly lower than that in the general population (6.3% vs. 36.8%, p = .02). CONCLUSION: This study indicates that despite a high false-positive rate of FIT in patients with inherited bleeding disorders, the detection rate of CRC and/or AA in hemophilia patients is high. FIT performs different in patients with hemophilia or VWD compared with the general population.
引用
- Kempers EK, van Kwawegen CB, de Meris J, et al. Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients. J Thromb Haemost. 2022. PMID: 36696188. doi:10.1016/j.jtha.2022.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。